资讯
A NEW weight loss jab that only needs to be taken once monthly leads to “substantial weight loss”, according to early trials.
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
MariTide is designed to combine the effects of glucagon-like peptide-1 (GLP-1) receptor activation with glucose-dependent ...
Amgen aims to challenge obesity drug leaders with MariTide, a potential monthly treatment now in late-stage trials.
In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...
There is a bottomless appetite for news about weight-loss drugs. We cannot hear enough about the celebrities, politicians and ...
7 小时
Zacks Investment Research on MSNNVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now?Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...
Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果